Changeflow GovPing Healthcare & Life Sciences US12606798B2 - Stem Cell Differentiation Method...
Routine Notice Added Final

US12606798B2 - Stem Cell Differentiation Methods and Compositions

Favicon for changeflow.com USPTO Patent Grants - Biotech (C12N)
Published
Detected
Email

Summary

USPTO granted US Patent 12606798B2 to Wisconsin Alumni Research Foundation covering methods and compositions for differentiating pluripotent stem cells into endothelial and hematopoietic lineages under defined conditions. The patent lists Igor Slukvin and Gene Ichiro Uenishi as inventors and contains 9 claims.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO granted Patent US12606798B2 covering methods and kits for hematoendothelial differentiation of human pluripotent stem cells under defined conditions. The patent is assigned to Wisconsin Alumni Research Foundation.

Affected parties include research institutions and biotechnology companies engaged in pluripotent stem cell work, particularly those focused on endothelial and hematopoietic lineage differentiation. The patent may affect freedom-to-operate analyses and licensing negotiations in the cell therapy and regenerative medicine space.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions

Grant US12606798B2 Kind: B2 Apr 21, 2026

Assignee

Wisconsin Alumni Research Foundation

Inventors

Igor Slukvin, Gene Ichiro Uenishi

Abstract

Methods, kits and compositions for differentiating pluripotent stem cells into cells of endothelial and hematopoietic lineages are disclosed.

CPC Classifications

C12N 5/0056 C12N 5/00

Filing Date

2022-04-07

Application No.

17715889

Claims

9

View original document →

Get daily alerts for USPTO Patent Grants - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12606798B2

Who this affects

Applies to
Healthcare providers Educational institutions Researchers
Industry sector
3254.1 Biotechnology
Activity scope
Patent granting Intellectual property registration Stem cell research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Grants - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!